PMID- 23936250 OWN - NLM STAT- MEDLINE DCOM- 20140305 LR - 20211021 IS - 1932-6203 (Electronic) IS - 1932-6203 (Linking) VI - 8 IP - 7 DP - 2013 TI - Dual-color fluorescence in situ hybridization reveals an association of chromosome 8q22 but not 8p21 imbalance with high grade invasive breast carcinoma. PG - e70790 LID - 10.1371/journal.pone.0070790 [doi] LID - e70790 AB - We previously reported molecular karyotype analysis of invasive breast tumour core needle biopsies by comparative genomic hybridization (CGH) and fluorescence in situ hybridization (FISH) (Walker et al, Genes Chromosomes Cancer, 2008 May;47(5):405-17). That study identified frequently recurring gains and losses involving chromosome bands 8q22 and 8p21, respectively. Moreover, these data highlighted an association between 8q22 gain and typically aggressive grade 3 tumors. Here we validate and extend our previous investigations through FISH analysis of tumor touch imprints prepared from excised breast tumor specimens. Compared to post-surgical tumor excisions, core needle biopsies are known to be histologically less precise when predicting tumor grade. Therefore investigating these chromosomal aberrations in tumor samples that offer more reliable pathological assessment is likely to give a better overall indication of association. A series of 60 breast tumors were screened for genomic copy number changes at 8q22 and 8p21 by dual-color FISH. Results confirm previous findings that 8p loss (39%) and 8q gain (74%) occur frequently in invasive breast cancer. Both absolute quantification of 8q22 gain across the sample cohort, and a separate relative assessment by 8q22:8p21 copy number ratio, showed that the incidence of 8q22 gain significantly increased with grade (p = 0.004, absolute and p = 0.02, relative). In contrast, no association was found between 8p21 loss and tumor grade. These findings support the notion that 8q22 is a region of interest for invasive breast cancer pathogenesis, potentially harboring one or more genes that, when amplified, precipitate the molecular events that define high tumor grade. FAU - Walker, Logan C AU - Walker LC AD - Cancer Genetics Research Group, Department of Pathology, University of Otago, Christchurch, New Zealand. logan.walker@otago.ac.nz FAU - McDonald, Margaret AU - McDonald M FAU - Wells, J Elisabeth AU - Wells JE FAU - Harris, Gavin C AU - Harris GC FAU - Robinson, Bridget A AU - Robinson BA FAU - Morris, Christine M AU - Morris CM LA - eng GR - Wellcome Trust/United Kingdom PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20130725 PL - United States TA - PLoS One JT - PloS one JID - 101285081 SB - IM MH - Aged MH - Breast Neoplasms/*diagnosis/genetics/mortality/surgery MH - Carcinoma, Ductal, Breast/*diagnosis/genetics/mortality/surgery MH - Chromosome Banding MH - *Chromosomes, Human, Pair 8 MH - DNA Copy Number Variations MH - Female MH - Humans MH - In Situ Hybridization, Fluorescence MH - Karyotyping MH - Mastectomy MH - Middle Aged MH - Neoplasm Grading MH - Survival Analysis MH - *Translocation, Genetic PMC - PMC3723675 COIS- Competing Interests: The authors have declared that no competing interests exist. EDAT- 2013/08/13 06:00 MHDA- 2014/03/07 06:00 PMCR- 2013/07/25 CRDT- 2013/08/13 06:00 PHST- 2013/03/05 00:00 [received] PHST- 2013/06/24 00:00 [accepted] PHST- 2013/08/13 06:00 [entrez] PHST- 2013/08/13 06:00 [pubmed] PHST- 2014/03/07 06:00 [medline] PHST- 2013/07/25 00:00 [pmc-release] AID - PONE-D-13-09253 [pii] AID - 10.1371/journal.pone.0070790 [doi] PST - epublish SO - PLoS One. 2013 Jul 25;8(7):e70790. doi: 10.1371/journal.pone.0070790. Print 2013.